What's In A Name? FDA To Rechristen Its Popular CMMI Maturity Model Appraisal Program This Year

The joint US FDA/MDIC Voluntary Medical Device Manufacturing and Product Quality Pilot Program – which aims to assess the manufacturing maturity of device firms – will be renamed the "Case for Quality Voluntary Improvement Program," or CFQ VIP. Meanwhile, MDIC says it has launched a new working group to guide development of the burgeoning initiative.

Female with name tag, hello my name is - Image

More from Regulation

More from Policy & Regulation